December 10, 2012 Arsenal Medical’s Foam Technology for Battlefield Injuries Receives $15.5 Million Phase II DARPA Contract Novel Arsenal foam technology to stabilize soldiers with severe abdominal hemorrhage, addressing major source of battlefield mortality.
